We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

52-Week Range
Valuation
Financials (FY2024)
Investment Thesis
Sequoia Healthcare is a small BSE-listed medical imaging company with a market cap of ₹55 Cr that manufactures MRI and CT scanners for the Indian market. While the healthcare equipment sector has strong structural tailwinds, the company faces intense competition from global giants and has very limited public disclosures, making it a high-risk proposition for investors.
Pros
Cons
Business Segments
Medical Imaging Equipment
Manufacturing and sales of MRI and CT scanner systems for hospitals and diagnostic centres
Revenue Model
Sequoia Healthcare earns revenue through the sale of MRI and CT scanner systems to hospitals, diagnostic centres, and healthcare institutions in India. Revenue is project/unit-sale based with potential service and maintenance contracts for installed equipment.
Detailed Analysis
Growth Plans
Government's Ayushman Bharat PM-JAY scheme driving hospital infrastructure expansion in smaller cities
PLI scheme for medical devices potentially supporting domestic manufacturing of imaging equipment
Industry Tailwinds
Government's Ayushman Bharat PM-JAY scheme driving hospital infrastructure expansion in smaller cities
PLI scheme for medical devices potentially supporting domestic manufacturing of imaging equipment
Comparable Companies
Frequently Asked Questions
About Sequoia Healthcare
Sequoia Healthcare is a BSE-listed medical equipment company based in Mumbai, specializing in the manufacture and sale of MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scanner systems for hospitals and diagnostic centers in India. The company reported revenues of approximately Rs. 77.6 Cr in FY2024. Sequoia targets the growing diagnostic imaging market in India where there is significant under-penetration of high-end imaging equipment per capita compared to global standards.
Key Milestones
Incorporated in 1985 in Delhi (CIN: L93000DL1985PLC021397)
BSE-listed medical equipment company focused on MRI and CT scanner manufacturing and sales in India
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Sequoia Healthcare — share your research, ask questions, or compare notes with other investors.
Industry Headwinds
Technology obsolescence risk as global players continuously upgrade MRI and CT platforms
Import competition from refurbished medical imaging equipment from Japan and Europe at competitive prices
Key Strengths
Domestic manufacturing advantage under Make-in-India
Growing Indian diagnostic imaging market
PLI scheme benefits for medical devices
Competitive pricing vs imported OEM systems
Key Weaknesses
Technology gap vs global OEMs (Siemens, GE, Philips)
Small scale limits R&D investment
Service network for high-precision equipment is critical and costly
Competes with global giants Siemens Healthineers, GE Healthcare, Philips, and Canon Medical, who dominate the Indian MRI/CT scanner market with superior technology and brand recognition
Source: AlphaHub Research
Market cap of only ₹55 Cr limits ability to invest in R&D or manufacturing scale upgrades required to remain competitive in high-tech medical imaging
Source: Company Financial Filings
Medical devices including MRI and CT scanners are subject to CDSCO (Central Drugs Standard Control Organisation) regulations in India, which can add compliance burden for small manufacturers
Source: Regulatory Filings
Technology gap vs global OEMs (Siemens, GE, Philips)
Source: AlphaHub Research
Small scale limits R&D investment
Source: AlphaHub Research
Service network for high-precision equipment is critical and costly
Source: AlphaHub Research
Competes with global giants Siemens Healthineers, GE Healthcare, Philips, and Canon Medical, who dominate the Indian MRI/CT scanner market with superior technology and brand recognition
Market cap of only ₹55 Cr limits ability to invest in R&D or manufacturing scale upgrades required to remain competitive in high-tech medical imaging
Medical devices including MRI and CT scanners are subject to CDSCO (Central Drugs Standard Control Organisation) regulations in India, which can add compliance burden for small manufacturers